Valuation: Precipio, Inc.

Market Cap 34.37M 31.2M 28.82M 26M 49.09M 3.21B 50.97M 347M 137M 1.73B 129M 126M 5.47B P/E 2024
-1.89x
P/E 2025 -102x
Enterprise Value 35.37M 32.11M 29.66M 26.76M 50.52M 3.3B 52.45M 357M 141M 1.78B 133M 130M 5.63B EV / Sales 2024
0.44x
EV / Sales 2025 1.72x
Free-Float
86.88%
Yield 2024 *
-
Yield 2025 -
1 day-2.87%
1 week-24.92%
Current month+2.87%
1 month-14.94%
3 months-24.58%
6 months-25.36%
Current year-18.97%
1 week 18.45
Extreme 18.45
24.8
1 month 17.79
Extreme 17.79
25.34
Current year 17.79
Extreme 17.79
33.63
1 year 17.79
Extreme 17.79
33.63
3 years 3.9
Extreme 3.9
33.63
5 years 3.9
Extreme 3.9
43.99
10 years 3.9
Extreme 3.9
8,448.01
Manager TitleAgeSince
Chief Operating Officer 41 -
Chief Tech/Sci/R&D Officer 42 01/06/2017
Chief Executive Officer 54 28/06/2017
Director TitleAgeSince
Director/Board Member 54 28/06/2017
Director/Board Member 78 26/09/2017
Director/Board Member 67 08/11/2017
Date Insider Type Main position Quantity % Market Cap. Importance
15/10/26 Free

Director

582 0.0325%
15/10/26 Free

Director

122 0.0068%
15/07/26 Free

Director

520 0.0291%
Change 5-day change 1-year change 3-year change Capi.($)
-2.87%-24.92%-20.36%+161.15% 34.32M
+0.41%-3.69%+20.00%+47.37% 254B
+0.56%-3.32%+0.88%+7.81% 159B
-0.59%-4.80%-21.73%+37.46% 149B
+1.85%-3.05%-55.90%-19.66% 62.37B
+0.15%+0.04%+25.96%+57.55% 60.62B
+1.25%+0.74%+5.46%-12.32% 53.05B
+1.73%-1.10%+21.67%+53.54% 48.55B
-2.09%-7.02%+3.53%+58.58% 46.7B
+2.86%-1.71%+22.90%+77.39% 44.21B
Average +0.36%-3.13%+0.24%+46.89% 88B
Weighted average by Cap. +0.49%-3.00%+2.95%+33.32%

Financials

2024 2025
Net sales 18.53M 16.82M 15.54M 14.02M 26.47M 1.73B 27.48M 187M 74.07M 934M 69.53M 68.07M 2.95B 24.05M 21.83M 20.17M 18.19M 34.35M 2.25B 35.66M 243M 96.12M 1.21B 90.23M 88.33M 3.83B
Net income -4.29M -3.89M -3.6M -3.25M -6.13M -401M -6.36M -43.35M -17.15M -216M -16.1M -15.76M -683M -363K -330K -304K -275K -518K -33.92M -538K -3.67M -1.45M -18.3M -1.36M -1.33M -57.82M
Net Debt -136K -123K -114K -103K -194K -12.71M -202K -1.37M -544K -6.86M -510K -500K -21.66M 1M 910K 840K 758K 1.43M 93.62M 1.49M 10.13M 4M 50.52M 3.76M 3.68M 160M
Projected Income Statement - Annual - Precipio, Inc.
Logo Precipio, Inc.
Precipio, Inc. is a healthcare biotechnology company that is focused on cancer diagnostics. The Company’s technologies include HemeScreen and IV-Cell. The HemeScreen panels test for the presence of various mutations. In developing HemeScreen, it focused on improving the economics of providing blood cancer diagnostic tests and reducing laboratory technician time consumed in the testing process. Its technology enables testing to be completed in one rapid scanning process. IV-Cell is a cell culture media that addresses the problem of diagnostic mistakes through the process of selective culturing. IV-Cell is a universal media that enables simultaneous culturing of all four hematopoietic cell lineages. Its product category includes Molecular Kits and IV-Cell Cytogenetics Media. The Molecular Kits include Quantitative MPN Panel, ABL1 Resistance Panel, and others. The Company’s laboratory and research and development (R&D) facilities are located in New Haven, Connecticut and Omaha, Nebraska.
Employees
66
Date Price Change Volume
18/11/26 $18.62 -2.87% 23,225
17/11/26 $19.17 -3.96% 46,288
16/11/26 $19.96 -9.81% 29,081
13/11/26 $22.13 -4.82% 14,710
12/11/26 $23.25 -6.25% 22,939
  1. Stock Market
  2. Stocks
  3. PRPO Stock